Gastrointestinal stromal tumors (GIST) can be successfully treated with imatinib mesylate (Gleevec);
however, complete remissions are rare and patients frequently achieve disease …

Most gastrointestinal stromal tumors (GIST) are caused by oncogenic KIT or platelet-derived
growth factor receptor activation, and the small molecule kinase inhibitor imatinib mesylate …

The majority of gastrointestinal stromal tumors (GISTs) are driven by oncogenic KIT signaling
and can therefore be effectively treated with the tyrosine kinase inhibitor (TKI) imatinib …

The outcomes of twins resulting from multifetal reduction were analyzed to examine whether
the outcome was improved over that of triplet and quadruplet pregnancies and similar to …

OBJECTIVE: This study was undertaken to report on the outcome of multifetal pregnancy
reduction in the most up-to-date largest single center experience with this procedure, and …

ASSISTED LISTENING DEVICES Thank you for joining us for today’s performance of the Illinois
State University Symphonic Winds. We hope that you will enjoy our concert, and that you …

Objective: Multifetal pregnancy reduction (MPR) is a technique developed to reduce the risks
of a multifetal pregnancy. The objective of this article was to report the outcome of MPR in …

Daptomycin (trade name: Cubicin), marketed by Cubist Pharmaceuticals, is a novel
lipoprotein antibiotic specific to gram-positive bacteria. It is effective in treating vancomycin-and …

The incidence of multifetal pregnancies has increased markedly over the past 20 years because
of advancements in assisted reproductive techniques. Despite efforts to avoid multifetal …

OBJECTIVE: To determine whether transabdominal selective termination of one or more
abnormal fetuses in a multifetal pregnancy with dichorionic placentation is a safe and effective …